MedTrace Logo

Study of Tolerance to Oral Peanut

NCT01259804 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2015-01-14

No results posted yet for this study

Summary

Open pilot study of peanut oral immunotherapy in 22 children with peanut allergy

Conditions

Interventions

DIETARY_SUPPLEMENT

Peanut oral immunotherapy

Daily doses of peanut flour

Sponsors & Collaborators

  • Cambridge University Hospitals NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Andrew T Clark, MB BD MD · Cambridge Biomedical Campus

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01259804 on ClinicalTrials.gov